Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05074225 · ClinicalTrials.gov registry record · NA
Aesthetic Outcome of Electrodesiccation and Curettage vs Excision With Complex Linear Closure
A NA study, sponsored by University of California, Davis.
- Terminated
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT05074225: Clinical Trial NA study, sponsored by University of California, Davis.
NCT05074225 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05074225, a NA study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether electrodesiccation and curettage (ED\&C) versus excision with complex linear closure affects esthetic outcomes (primary outcome). As secondary outcome, we plan to look at patient quality of life measures and complications. This will be a prospective, 2-arm, randomized, evaluator-blinded clinical trial. One half of the patients will receive ED\&C and the other half will receive excision with repair by complex linear closure. Three-months post-surgery, the scar will be evaluated via the patient observer scar assessment scale (POSAS), a validated scar instrument, as well as the trace-to-tape method, an objective outcome measure for linear postoperative scars. In addition, patients will be provided a validated quality of life survey to complete. Any adverse events will also be recorded.
Primary Outcome
The primary endpoints will be (1) the score of two blinded reviewers using the patient observer scar assessment score and (2) the mean scar area to preoperative cancer area ratio using the trace-to-tape method at a three-month assessment visit.
Interventions
- OTHER Electrodesiccation and Curettage vs Excision
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2022-06-08 |
| Phase | NA |
Why NCT05074225 stopped before completion
NCT05074225 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Electrodesiccation and Curettage vs Excision is the first listed.
NCT05074225 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05074225 about?
NCT05074225 is a clinical study titled "Aesthetic Outcome of Electrodesiccation and Curettage vs Excision With Complex Linear Closure". The purpose of this study is to determine whether electrodesiccation and curettage (ED\&C) versus excision with complex linear closure affects esthetic outcomes (primary outcome). As secondary outcome, we plan to look at patient quality of life measures and complications. This will be a prospective,...
What is the current status of trial NCT05074225?
This trial is currently terminated. It is a NA study. The enrollment target is 59 participants. The study started on 2020-02-03. Estimated completion is 2022-06-08.
What interventions are being tested in trial NCT05074225?
The interventions under investigation include: Electrodesiccation and Curettage vs Excision (OTHER).
Who is sponsoring clinical trial NCT05074225?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05074225's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI